Healthcare Realty Trust Incorporated (HR)
(Delayed Data from NYSE)
$14.38 USD
+0.15 (1.05%)
Updated Apr 23, 2024 03:59 PM ET
After-Market: $14.37 -0.01 (-0.07%) 5:22 PM ET
4-Sell of 5 4
C Value C Growth A Momentum B VGM
Income Statements
Fiscal Year end for Healthcare Realty Trust Incorporated falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,344 | 933 | 767 | 739 | 692 |
Cost Of Goods | 500 | 344 | 237 | 227 | 211 |
Gross Profit | 843 | 589 | 530 | 512 | 481 |
Selling & Adminstrative & Depr. & Amort Expenses | 789 | 612 | 377 | 348 | 334 |
Income After Depreciation & Amortization | 54 | -24 | 153 | 164 | 146 |
Non-Operating Income | -78 | 211 | 39 | -16 | -19 |
Interest Expense | 259 | 147 | 93 | 95 | 97 |
Pretax Income | -282 | 41 | 100 | 54 | 31 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | -4 | 0 | 2 | 1 | 1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -282 | 41 | 100 | 54 | 31 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -278 | 41 | 98 | 53 | 30 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 797 | 434 | 437 | 447 | 427 |
Depreciation & Amortization (Cash Flow) | 743 | 458 | 283 | 283 | 281 |
Income After Depreciation & Amortization | 54 | -24 | 153 | 164 | 146 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 378.93 | 253.87 | 224.22 | 221.67 | 209.61 |
Diluted EPS Before Non-Recurring Items | -0.74 | 0.15 | 0.44 | 0.24 | 0.25 |
Diluted Net EPS (GAAP) | -0.74 | 0.15 | 0.44 | 0.24 | 0.14 |
Fiscal Year end for Healthcare Realty Trust Incorporated falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 330.44 | 342.26 | 338.14 | 332.93 |
Cost Of Goods | NA | 121.36 | 131.64 | 125.40 | 122.04 |
Gross Profit | NA | 209.08 | 210.62 | 212.75 | 210.89 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 196.37 | 204.61 | 183.65 | 204.56 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 12.71 | 6.01 | 29.10 | 6.33 |
Non-Operating Income | NA | 8.81 | -8.32 | -47.48 | -30.65 |
Interest Expense | NA | 63.19 | 66.30 | 65.33 | 63.76 |
Pretax Income | NA | -41.68 | -68.60 | -83.73 | -88.08 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | -1.14 | -0.76 | -0.97 | -0.95 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -41.68 | -68.60 | -83.73 | -88.08 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -40.53 | -67.84 | -82.76 | -87.13 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 379.04 | 378.93 | 378.90 | 378.84 |
Diluted EPS Before Non-Recurring Items | NA | -0.11 | -0.18 | -0.22 | -0.23 |
Diluted Net EPS (GAAP) | NA | -0.11 | -0.18 | -0.22 | -0.23 |